STIOLTO RESPIMAT- tiotropium bromide and olodaterol spray, metered United States - English - NLM (National Library of Medicine)

stiolto respimat- tiotropium bromide and olodaterol spray, metered

boehringer ingelheim pharmaceuticals inc. - tiotropium bromide monohydrate (unii: l64sxo195n) (tiotropium - unii:0eb439235f), olodaterol hydrochloride (unii: 65r445w3v9) (olodaterol - unii:vd2ysn1afd) - tiotropium 3.124 ug - stiolto respimat is a combination of tiotropium and olodaterol indicated for long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema. important limitations of use - stiolto respimat is not indicated to treat acute deteriorations of copd [see warnings and precautions (5.2)]. - stiolto respimat is not indicated to treat asthma. the safety and effectiveness of stiolto respimat in asthma have not been established. use of a laba, including stiolto respimat, without an inhaled corticosteroid is contraindicated in patients with asthma [see warnings and precautions (5.1)] . stiolto respimat is not indicated for the treatment of asthma. stiolto respimat is contraindicated in patients with a hypersensitivity to tiotropium, ipratropium, olodaterol, or any component of this product [see warnings and precautions (5.4)] . in clinical trials and postmarketing experience with tiotropium, immediate hypersensitivity reactions, inc

SPIOLTO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for in Australia - English - Department of Health (Therapeutic Goods Administration)

spiolto respimat 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for in

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - spiolto respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

SPIOLTO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inhalation cartridge (with dose indicator) Australia - English - Department of Health (Therapeutic Goods Administration)

spiolto respimat 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inhalation cartridge (with dose indicator)

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - spiolto respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

YANIMO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inh Australia - English - Department of Health (Therapeutic Goods Administration)

yanimo respimat 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inh

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - yanimo respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Tiotropium Mylan 18 micrograms/dose inhalation powder, hard capsule Ireland - English - HPRA (Health Products Regulatory Authority)

tiotropium mylan 18 micrograms/dose inhalation powder, hard capsule

mcdermott laboratories ltd., t/a gerard laboratories - tiotropium - inhalation powder, hard capsule - 18 microgram(s) - tiotropium bromide

Tiotropium DEMO, 18 microgram, inhalation powder, hard capsule Malta - English - Medicines Authority

tiotropium demo, 18 microgram, inhalation powder, hard capsule

demo s.a. pharmaceutical industry 21st km national road athens - lamia 14568 krioneri, greece - tiotropium bromide - inhalation powder, hard capsule - tiotropium bromide 21.7 µg - drugs for obstructive airway diseases

Yanimo Respimat Malta - English - Medicines Authority

yanimo respimat

boehringer ingelheim international gmbh binger strasse 173, 55216 ingelheim am rhein, germany - olodaterol, tiotropium bromide - inhalation vapour, solution - olodaterol 2.5 µg tiotropium bromide 2.5 µg - drugs for obstructive airway diseases

Spiolto Respimat 2.5 microgram/2.5 microgram, inhalation solution Malta - English - Medicines Authority

spiolto respimat 2.5 microgram/2.5 microgram, inhalation solution

boehringer ingelheim international gmbh binger strasse 173, 55216 ingelheim am rhein, germany - olodaterol, tiotropium bromide - inhalation vapour, solution - olodaterol 2.5 µg tiotropium bromide 2.5 µg - drugs for obstructive airway diseases